+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Cough Remedies Market Size, Share & Trends Analysis Report By Age (Adult and Pediatric), By Distribution Channel (Retail Pharmacy, Hospital and Online Pharmacies), By Type, By Dosage. By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 125 Pages
  • March 2024
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5953791
The Asia Pacific Cough Remedies Market would witness market growth of 6.0% CAGR during the forecast period (2023-2030).

The China market dominated the Asia Pacific Cough Remedies Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $823.4 million by 2030. The Japan market is registering a CAGR of 5.3% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 6.6% during (2023 - 2030).



Manufacturers are increasingly formulating combination cough remedies targeting multiple symptoms or underlying causes of cough. These formulations often integrate cough suppressants, expectorants, antihistamines, and analgesics to provide comprehensive relief from cough and associated symptoms such as congestion, pain, and inflammation. Combination cough remedies offer several advantages over single-ingredient formulations, including enhanced convenience, simplified dosing regimens, and improved patient compliance. By consolidating multiple active ingredients into a single product, manufacturers streamline the treatment process, reducing the need for individuals to purchase and administer multiple medications separately.

Additionally, Advances in pharmacology and understanding of cough pathophysiology have led to targeted therapies tailored to specific cough types and mechanisms. Examples include neuromodulators targeting cough reflex pathways, mucus-modifying agents to enhance airway clearance, and immunomodulators addressing inflammatory cough conditions. These agents can suppress cough hypersensitivity and reduce cough frequency by modulating neuronal signaling in the central nervous system or peripheral nerves. Such precision in targeting underlying neurogenic mechanisms holds promise for treating refractory or chronic cough conditions.

The rising cases of respiratory diseases in Australia are expected to impact the demand for cough remedies directly. As per the Government of Australia, based on self-reported data from NHS 2020-21, nearly 30% of Australians said they had long-term respiratory illnesses. Thus, the rising pharmaceutical sector and increasing respiratory disease cases in the Asia Pacific will propel the demand for cough remedies in the region.

Based on Age, the market is segmented into Adult and Pediatric. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital and Online Pharmacies. Based on Type, the market is segmented into Expectorants, Antihistamines, Bronchodilators, Antibiotics and Others. Based on Dosage, the market is segmented into Oral Syrup, Tablets & Pills, Lozenges, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

  • Himalaya Global Holdings Ltd.
  • Nature's Way Products LLC (Dr. Willmar Schwabe GmbH & Co. KG)
  • Pfizer, Inc.
  • Amway Corporation
  • NOW Foods, Inc.
  • Wakunaga of America Co., Ltd. (Wakunaga Pharmaceutical Co., Ltd.)
  • Nu Skin Enterprises, Inc.
  • Nature’s Sunshine Products, Inc.
  • Neurobiologix, Inc.
  • Nordic Naturals, Inc.

Market Report Segmentation

By Age
  • Adult
  • Pediatric
By Distribution Channel
  • Retail Pharmacy
  • Hospital
  • Online Pharmacies
By Type
  • Expectorants
  • Antihistamines
  • Bronchodilators
  • Antibiotics
  • Others
By Dosage
  • Oral Syrup
  • Tablets & Pills
  • Lozenges
  • Others
By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Cough Remedies Market, by Age
1.4.2 Asia Pacific Cough Remedies Market, by Distribution Channel
1.4.3 Asia Pacific Cough Remedies Market, by Type
1.4.4 Asia Pacific Cough Remedies Market, by Dosage
1.4.5 Asia Pacific Cough Remedies Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Asia Pacific Cough Remedies Market by Age
4.1 Asia Pacific Adult Market by Country
4.2 Asia Pacific Pediatric Market by Country
Chapter 5. Asia Pacific Cough Remedies Market by Distribution Channel
5.1 Asia Pacific Retail Pharmacy Market by Country
5.2 Asia Pacific Hospital Market by Country
5.3 Asia Pacific Online Pharmacies Market by Country
Chapter 6. Asia Pacific Cough Remedies Market by Type
6.1 Asia Pacific Expectorants Market by Country
6.2 Asia Pacific Antihistamines Market by Country
6.3 Asia Pacific Bronchodilators Market by Country
6.4 Asia Pacific Antibiotics Market by Country
6.5 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific Cough Remedies Market by Dosage
7.1 Asia Pacific Oral Syrup Market by Country
7.2 Asia Pacific Tablets & Pills Market by Country
7.3 Asia Pacific Lozenges Market by Country
7.4 Asia Pacific Others Market by Country
Chapter 8. Asia Pacific Cough Remedies Market by Country
8.1 China Cough Remedies Market
8.1.1 China Cough Remedies Market by Age
8.1.2 China Cough Remedies Market by Distribution Channel
8.1.3 China Cough Remedies Market by Type
8.1.4 China Cough Remedies Market by Dosage
8.2 Japan Cough Remedies Market
8.2.1 Japan Cough Remedies Market by Age
8.2.2 Japan Cough Remedies Market by Distribution Channel
8.2.3 Japan Cough Remedies Market by Type
8.2.4 Japan Cough Remedies Market by Dosage
8.3 India Cough Remedies Market
8.3.1 India Cough Remedies Market by Age
8.3.2 India Cough Remedies Market by Distribution Channel
8.3.3 India Cough Remedies Market by Type
8.3.4 India Cough Remedies Market by Dosage
8.4 South Korea Cough Remedies Market
8.4.1 South Korea Cough Remedies Market by Age
8.4.2 South Korea Cough Remedies Market by Distribution Channel
8.4.3 South Korea Cough Remedies Market by Type
8.4.4 South Korea Cough Remedies Market by Dosage
8.5 Singapore Cough Remedies Market
8.5.1 Singapore Cough Remedies Market by Age
8.5.2 Singapore Cough Remedies Market by Distribution Channel
8.5.3 Singapore Cough Remedies Market by Type
8.5.4 Singapore Cough Remedies Market by Dosage
8.6 Malaysia Cough Remedies Market
8.6.1 Malaysia Cough Remedies Market by Age
8.6.2 Malaysia Cough Remedies Market by Distribution Channel
8.6.3 Malaysia Cough Remedies Market by Type
8.6.4 Malaysia Cough Remedies Market by Dosage
8.7 Rest of Asia Pacific Cough Remedies Market
8.7.1 Rest of Asia Pacific Cough Remedies Market by Age
8.7.2 Rest of Asia Pacific Cough Remedies Market by Distribution Channel
8.7.3 Rest of Asia Pacific Cough Remedies Market by Type
8.7.4 Rest of Asia Pacific Cough Remedies Market by Dosage
Chapter 9. Company Profiles
9.1 Himalaya Global Holdings Ltd.
9.1.1 Company Overview
9.1.2 SWOT Analysis
9.2 Nature's Way Products LLC (Dr. Willmar Schwabe GmbH & Co. KG)
9.2.1 Company Overview
9.2.2 SWOT Analysis
9.3 Pfizer, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional & Segmental Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Acquisition and Mergers:
9.3.6 SWOT Analysis
9.4 Amway Corporation
9.4.1 Company Overview
9.4.2 SWOT Analysis
9.5 NOW Foods, Inc.
9.5.1 Company Overview
9.5.2 SWOT Analysis
9.6 Wakunaga of America Co., Ltd. (Wakunaga Pharmaceutical Co., Ltd.)
9.6.1 Company Overview
9.6.2 SWOT Analysis
9.7 Nu Skin Enterprises, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental Analysis
9.7.4 Research & Development Expenses
9.7.5 SWOT Analysis
9.8 Nature’s Sunshine Products, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental Analysis
9.8.4 Research & Development Expenses
9.8.5 SWOT Analysis
9.9 Neurobiologix, Inc.
9.9.1 Company Overview
9.9.2 SWOT Analysis
9.10. Nordic Naturals, Inc.
9.10.1 Company Overview
9.10.2 SWOT Analysis

Companies Mentioned

  • Himalaya Global Holdings Ltd.
  • Nature's Way Products LLC (Dr. Willmar Schwabe GmbH & Co. KG)
  • Pfizer, Inc.
  • Amway Corporation
  • NOW Foods, Inc.
  • Wakunaga of America Co., Ltd. (Wakunaga Pharmaceutical Co., Ltd.)
  • Nu Skin Enterprises, Inc.
  • Nature’s Sunshine Products, Inc.
  • Neurobiologix, Inc.
  • Nordic Naturals, Inc.

Methodology

Loading
LOADING...